Bria-Lung

N/A

Report date: 2025/03/14 16:32:53

Base Information

Drug NameBria-Lung
Drug Alias Namegenetically engineered cell therapy BriaCell Therapeutics
ClassificationCell and gene therapy > Cell therapy
Mechanisms of ActionInterferon alpha ligandGranulocyte-macrophage colony-stimulating factor receptor modulators
TargetsInterferon alphaGranulocyte-macrophage colony-stimulating factor receptor
Therapy Area/IndicationsCarcinoma, Non-Small-Cell Lung
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesBriacell Therapeutics Corp
China Registration ClassN/A

Develop Information

Active CompaniesBriacell Therapeutics Corp
Inactive CompaniesN/A
Active IndicationsCarcinoma, Non-Small-Cell Lung
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A